GB201517995D0 - Products for treating psychogenic pain disorders - Google Patents

Products for treating psychogenic pain disorders

Info

Publication number
GB201517995D0
GB201517995D0 GBGB1517995.5A GB201517995A GB201517995D0 GB 201517995 D0 GB201517995 D0 GB 201517995D0 GB 201517995 A GB201517995 A GB 201517995A GB 201517995 D0 GB201517995 D0 GB 201517995D0
Authority
GB
United Kingdom
Prior art keywords
products
pain disorders
psychogenic pain
treating
treating psychogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1517995.5A
Other versions
GB2543271A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hermann Dr L H
Original Assignee
Hermann Dr L H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hermann Dr L H filed Critical Hermann Dr L H
Priority to GB1517995.5A priority Critical patent/GB2543271A/en
Publication of GB201517995D0 publication Critical patent/GB201517995D0/en
Priority to PCT/EP2016/074417 priority patent/WO2017064098A1/en
Publication of GB2543271A publication Critical patent/GB2543271A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1517995.5A 2015-10-12 2015-10-12 Products for treating psychogenic pain disorders Withdrawn GB2543271A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1517995.5A GB2543271A (en) 2015-10-12 2015-10-12 Products for treating psychogenic pain disorders
PCT/EP2016/074417 WO2017064098A1 (en) 2015-10-12 2016-10-12 Products for treating psychogenic pain disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1517995.5A GB2543271A (en) 2015-10-12 2015-10-12 Products for treating psychogenic pain disorders

Publications (2)

Publication Number Publication Date
GB201517995D0 true GB201517995D0 (en) 2015-11-25
GB2543271A GB2543271A (en) 2017-04-19

Family

ID=55130904

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1517995.5A Withdrawn GB2543271A (en) 2015-10-12 2015-10-12 Products for treating psychogenic pain disorders

Country Status (2)

Country Link
GB (1) GB2543271A (en)
WO (1) WO2017064098A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2104229C (en) * 1991-02-25 1997-04-15 Conan Kornetsky Opiate receptor antagonist modulates movement disorder
EP1061924A1 (en) * 1998-03-09 2000-12-27 Trustees Of Tufts College Treatment of compulsive behaviours in man and animals
US6897242B1 (en) * 1999-02-24 2005-05-24 Judson J. Somerville Non-racemic mixtures of d- and l- methadone and method of treating pain
US20130197015A1 (en) * 2009-12-22 2013-08-01 Pondera Biotechnologies, LLC Novel method to improve the safety and efficacy of caffeine
WO2014170352A1 (en) * 2013-04-17 2014-10-23 H. Lundbeck A/S Nalmefene for treatment of patients with anxiety disorder

Also Published As

Publication number Publication date
WO2017064098A1 (en) 2017-04-20
GB2543271A (en) 2017-04-19

Similar Documents

Publication Publication Date Title
HK1252978A1 (en) Compounds for use in treating neuromuscular disorders
HK1259336A1 (en) Methods for treating myeloproliferative disorders
ZA201705673B (en) Methods for treating skin
IL285151A (en) Methods of treating fgf21-associated disorders
IL253945A0 (en) Kdm1a inhibitors for the treatment of disease
IL279308A (en) Methods for treating hepcidin-mediated disorders
HK1256036A1 (en) Methods for treating myeloproliferative disorders
IL278247B (en) Mct4 inhibitors for treating disease
HK1244217A1 (en) Methods for treating proteinopathies
HK1253238A1 (en) Gls1 inhibitors for treating disease
PT3119911T (en) Methods for treating neurological disorders
HK1252996A1 (en) Methods for the treatment of epilepsy
PT3164394T (en) Gls1 inhibitors for treating disease
IL250114B (en) Methods and compositions for treating hiv-related disorders
HK1248130A1 (en) Composition for treating pain
GB201604658D0 (en) Treatment for pain
IL234962A0 (en) Use of agents for treating fat-related disorders
GB201517995D0 (en) Products for treating psychogenic pain disorders
GB201505205D0 (en) Treatment for pain
GB201504688D0 (en) Treatment for pain
GB201602011D0 (en) Treating skin disorders
GB201511895D0 (en) Combination therapy for treating multiple sclerosis

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)